Imprimis Pharmaceuticals (Nasdaq: IMMY) is a pharmaceutical company dedicated to delivering high-quality and innovative medicines to physicians and patients at affordable prices. We are pioneering a new commercial pathway in the pharmaceutical industry, using compounding pharmacies for the formulation and distribution of high-quality formulations that are supported by the clinical experience of physicians and their patients.

We offer proprietary compounded formulations in areas including ophthalmology, urology, and dermatology; however we also have other formulations outside of our core therapeutic areas including sinus therapy and integrative medications. VIEW WEBSITE